Home > Healthcare > Pharmaceuticals > Vaccines > mRNA Vaccine Market
mRNA Vaccine Market Share
- Report ID: GMI6076
- Published Date: Jun 2023
- Report Format: PDF
mRNA Vaccine Market Share
Major market players operating in the mRNA vaccine market include
- AstraZeneca
- Pfizer Inc.
- Moderna, Inc.
- GlaxoSmithKline
These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
Frequently Asked Questions (FAQ) :
mRNA vaccine industry size was worth USD 11.3 billion in 2022 and is projected to expand at 9.6% CAGR to reach USD 27.7 billion by the end of 2032 driven by the high prevalence of infectious diseases and genetic disorders worldwide.
Demand for self-amplifying mRNA vaccines reached 50.9% of the market share in 2022 and is estimated to grow at a notable CAGR from 2023-2032 attributed to their increasing adoption to achieve dose-sparing effects.
North America held more than 42.4% share of the mRNA vaccine market in 2022 and is anticipated to exhibit considerable growth through 2032 attributed to the presence of well-established healthcare infrastructure and the increasing R&D investments by led key market players.
Some of the mRNA vaccine firms include AstraZeneca, Pfizer Inc., Moderna, Inc., and GlaxoSmithKline among others.
mRNA Vaccine Market Scope
×
Get a free sample of
mRNA Vaccine Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below